Clinical trials

  • ORISMILAST for Obesity
  • glycopyrronium bromide | neostigmine methylsulfate for Residual neuromuscular blockade (reappearance of non-depolarizing neuromuscular block after reversal with neostigmine)
  • Human normal immunoglobulin; Hyaluronidase (human recombinant) for Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
  • ICOSAPENT ETHYL for Aortic valve stenosis
  • IOMX-0675 for Advanced/metastatic solid tumors | Non-small cell lung cancer | Gastric cancer | Gastro-esophageal junction cancer | Mesothelioma | Renal cell carcinoma | Colorectal cancer (MSS/pMMR)
  • Ixazomib for Multiple myeloma
  • OPEVESOSTAT for Metastatic castration-resistant prostate cancer
  • TAMOXIFEN CITRATE for Breast cancer|Vulvovaginal atrophy
  • CIPROFLOXACIN for VRE carriage | ESBL carriage
  • INFLIXIMAB for Ulcerative colitis
  • RELACORILANT for Gynecological cancers | Ovarian cancer | Endometrial cancer | Fallopian tube cancer | Peritoneal neoplasm
  • FOLLITROPIN BETA for Female subfertility | Subfertility requiring ICSI